Related Experiment Videos
The daughters of diethylstilbestrol. Lessons from an error
M Tournaire1, J Lepercq, S Epelboin
1Department of Gynecology and Obstetrics, Hôpital Saint Vincent de Paul, Paris, France.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|February 3, 1998
Summary
Diethylstilbestrol (DES) use varied across Europe for preventing pregnancy issues. Lessons learned from DES inform research, physician communication, and clinical guidelines for conditions like clear cell adenocarcinoma and infertility.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Public Health
Background:
- Diethylstilbestrol (DES) was widely used in Europe to prevent pregnancy complications.
- Its usage and impact varied significantly between countries.
- The historical use of DES offers critical lessons for medical practice and research.
Purpose of the Study:
- To analyze the incidence and implications of Diethylstilbestrol (DES) use within a specific clinical practice.
- To propose evidence-based guidelines for managing DES-related conditions.
- To highlight the long-term consequences of pharmaceutical interventions in pregnancy.
Main Methods:
- Retrospective review of clinical cases involving Diethylstilbestrol (DES) exposure.
- Analysis of epidemiological data on DES usage patterns.
- Development of clinical management protocols based on observed outcomes.
Main Results:
- Documented incidence of DES-related conditions such as clear cell adenocarcinoma, adenosis, and cervical dysplasia.
- Observed effects on infertility and pregnancy outcomes in DES-exposed individuals.
- Identification of key areas for improved physician information and patient communication.
Conclusions:
- The legacy of Diethylstilbestrol (DES) necessitates ongoing vigilance and specialized care.
- Clinical guidelines are crucial for addressing the spectrum of DES-associated health issues.
- Learning from the DES experience is vital for future pharmaceutical research and regulatory practices.